Trimetazidine does not modify blood levels and immunosuppressant effects of cyclosporine A in renal allograft recipients

Aims In renal allograft recipients, trimetazidine (Vastarel(®) ) was proposed to be associated with the classic immunosuppressant treatments because it displays anti-ischaemic effects which may protect against cyclosporine A nephrotoxicity. The objective of this work was to assess the possibility of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Simon, Nicolas, Brunet, Philippe, Roumenov, Dimitri, Dussol, Bertrand, Barre, Jerome, Duche, Jean-Claude, Albengres, Edith, D’Athis, Philippe, Chauvet-Monges, Anne-Marie, Berland, Yvon, Tillement, Jean-Paul
Formato: Artigo
Idioma:Inglês
Publicado em: 1997
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2042879/
https://ncbi.nlm.nih.gov/pubmed/9431838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.1997.t01-1-00628.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados